| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 141, Issue 10 3405-3409, Copyright © 1988 by American Association of Immunologists
ARTICLES |
DA Hume, P Pavli, RE Donahue and IJ Fidler
Department of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Human recombinant macrophage CSF (CSF-1) was administered i.v. to mice. After four daily injections there was a dose-dependent increase in the responsiveness of bone marrow cells from the treated animals to CSF-1 in vitro. At the highest dose tested (20,000 U/day) there was a selective 10-fold increase in the circulating population of mature monocytes. CSF-1 treatment also increased the macrophage content of the liver and peritoneal cavity and caused splenomegaly. The macrophages isolated from the peritoneum of CSF-1-treated animals were larger and expressed higher levels of the macrophage-specific F4/80 Ag. These data demonstrate that CSF-1 can act as a circulating regulator of the mononuclear phagocyte system.
This article has been cited by other articles:
|
|
 |
|
  A. Bye, M. Langaas, M. A. Hoydal, O. J. Kemi, G. Heinrich, L. G. Koch, S. L. Britton, S. M. Najjar, O. Ellingsen, and U. Wisloff Aerobic capacity-dependent differences in cardiac gene expression Physiol Genomics, October 8, 2008; 33(1): 100 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shrivastav, S. Varma, Z. Lawman, S. H. Yang, S. A. Ritchie, K. Bonham, S. M. Singh, A. Saxena, and R. K. Sharma Requirement of N-Myristoyltransferase 1 in the Development of Monocytic Lineage J. Immunol., January 15, 2008; 180(2): 1019 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Irvine, C. J. Burns, A. F. Wilks, S. Su, D. A. Hume, and M. J. Sweet A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations FASEB J, September 1, 2006; 20(11): 1921 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Conway, B. McDonald, J. Parham, B. Keith, D. W. Rusnak, E. Shaw, M. Jansen, P. Lin, A. Payne, R. M. Crosby, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580 PNAS, November 1, 2005; 102(44): 16078 - 16083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Frangogiannis, L. H. Mendoza, G. Ren, S. Akrivakis, P. L. Jackson, L. H. Michael, C. W. Smith, and M. L. Entman MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H483 - H492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Oren, N. Duman, H. Abacioglu, H. Ozkan, and G. Irken Association Between Serum Macrophage Colony-Stimulating Factor Levels and Monocyte and Thrombocyte Counts in Healthy, Hypoxic, and Septic Term Neonates Pediatrics, August 1, 2001; 108(2): 329 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Campbell, M. J. Rich, R. J. Bischof, and J. A. Hamilton The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF J. Leukoc. Biol., July 1, 2000; 68(1): 144 - 150. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Kuhara, K. Uchida, and H. Yamaguchi Therapeutic Efficacy of Human Macrophage Colony-Stimulating Factor, Used Alone and in Combination with Antifungal Agents, in Mice with Systemic Candida albicans Infection Antimicrob. Agents Chemother., January 1, 2000; 44(1): 19 - 23. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Lemay, T. V. Lebedeva, and A. K. Singh Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-kappa B-Independent Mechanism Clin. Vaccine Immunol., July 1, 1999; 6(4): 567 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Lichanska, C. M. Browne, G. W. Henkel, K. M. Murphy, M. C. Ostrowski, S. R. McKercher, R. A. Maki, and D. A. Hume Differentiation of the Mononuclear Phagocyte System During Mouse Embryogenesis: The Role of Transcription Factor PU.1 Blood, July 1, 1999; 94(1): 127 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chan, P. J.M. Leenen, I. Bertoncello, S.-I. Nishikawa, and J. A. Hamilton Macrophage Lineage Cells in Inflammation: Characterization by Colony-Stimulating Factor-1 (CSF-1) Receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) Expression Blood, August 15, 1998; 92(4): 1423 - 1431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Baker and J. Levin Transient Thrombocytopenia Produced by Administration of Macrophage Colony-Stimulating Factor: Investigations of the Mechanism Blood, January 1, 1998; 91(1): 89 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jessup, B. Squires, L. Kritharides, D. A. Hume, and R. T. Dean Effects of CSF-1 on Cholesterol Accumulation and Efflux by Macrophages Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 18 - 25. [Abstract] [Full Text]
|
|
|
|
 |
|
 Q. Li and S. Yokoyama Independent Regulation of Cholesterol Incorporation into Free Apolipoprotein-mediated Cellular Lipid Efflux in Rat Vascular Smooth Muscle Cells J. Biol. Chem., November 3, 1995; 270(44): 26216 - 26223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cecchini, M. Dominguez, S Mocci, A Wetterwald, R Felix, H Fleisch, O Chisholm, W Hofstetter, J. Pollard, and E. Stanley Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse Development, January 6, 1994; 120(6): 1357 - 1372. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
